- Pollard KM, Pearson DL, Hultman P, et al. Lupus-prone mice as models to study xenobiotic-induced acceleration of systemic autoimmunity. Environ Health Perspect 1999; 107(suppl 5):729-35.
- Shaheen VM, Satoh M, Richards HB, et al. Immunopa-thogenesis of environmentally induced lupus in mice. Environ Health Perspect 1999; 107(suppl 5):723-7.
- Aryal BK, Khuder SA, Schaub EA. Meta-analysis of systemic sclerosis and exposure to solvents. Am J Ind Med 2001; 40:271-4.
- Nietert PJ, Sutherland SE, Silver RM, et al. Solvent oriented hobbies and the risk of systemic sclerosis. J Rheumatol 1999; 26:2369-72.
- Barr RD. The mercurial nephrotic syndrome. E Afr Med J 1990; 67:381-6.
- Powell JJ, Van de Water J, Gershwin ME. Evidence for the role of environmental agents in the initiation or progression of autoimmune conditions. Environ Health Perspect 1999; 107(suppl 5):667-72.
- Parks C, Conrad K, Cooper G. Occupational exposure to crystalline silica and autoimmune disease. Environ Health Perspect 1999; 107:793-802.
- Oil Sands Discovery Centre. 2003. Home page. http://www.oilsandsdiscovery.com> Accessed February 21, 2003.
- Health Surveillance, Alberta Health and Wellness. The Alberta Oil Sands Community Exposure and Health Effects Assessment Program. Edmondton, Alberta, Canada: Government of Alberta, 2000.
- Lebowitz MD, Quackenboss JJ, Kollander M, et al. The new standard environmental inventory questionnaire for estimation of indoor concentrations. J Air Pollut Control Assoc 1989; 39:1411-19.
- Air Resources Branch. The Windsor winter 1992 Personal Exposure Pilot (PEP) study. Toronto, Ontario, Canada: Ontario Ministry of the Environment, 1992.
- Ware JE jr., Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992; 30:473-83.
- Tan EM, Feltkamp TEW, Smolen JS, et al. Range of antinuclear antibodies in "healthy" individuals. Arthritis Rheum 1997; 40:1601-11.
- von Muhlen CA, Tan EM. Autoantibodies in the diagnosis of systemic rheumatic diseases. Semin Arthritis Rheum 1995; 24:323-58.
- Jacobson DL, Gange SJ, Rose NR, et al. Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin Immunol Immunopathol 1997; 84:223-43.
- Rubin RL, Burlingame RW. Biochemical mechanisms in autoimmunity. Biochem Soc Trans 1991; 19:153-9.
- Via CS, Nguyen P, Niculescu F, et al. Low-dose exposure to inorganic mercury accelerates disease and mortality in acquired murine lupus. Environ Health Perspect 2003; 111:1273-7.
- Hudson CA, Cao L, Kasten-Jolly J, et al. Susceptibility of lupus-prone NZM mouse strains to lead exacerbation of systemic lupus erythematosus symptoms. J Toxicol Environ Health A 2003; 66:895-918.
- Weisel C, Yu R, Roy A, et al. Biomarkers of environmental benzene exposure. Environ Health Perspect 1996; 104:1141-6.
- Arnett FC, Fritzler MJ, Ahn C, et al. Urinary mercury levels in patients with autoantibodies to U3-RNP (fibrillarin). J Rheumatol 2000; 27:405-10.
- World Health Organization. International classification of diseases, ninth revision: basic tabulation list with alphabetical index. 4th ed. Geneva: World Health Organization, 1978.
- Burlingame RW, Cervera R. Anti-chromatin (anti-nucleo-some) autoantibodies. Autoimmun Rev 2002;1:321-8.
Archives of Environmental Health: An International Journal
Volume 59, 2004 - Issue 3